Research and Development for Global Health
Over the past decade, China and India have emerged as hotbeds of innovation for new biomedical products that have benefitted millions of people throughout the developing world. At this session expert panelists will discuss each nation’s contributions in this area; describe the policy priorities that have set the stage for recent R&D activities; identify barriers to continued R&D expansion; and discuss the optimal mix of incentives and regulations that can stimulate further growth in this sector.
Dr. J. Stephen Morrison, Moderator
Senior Vice President; Director, Global Health Policy Center; Center for Strategic and International Studies
Dr. Paul Wilson
Senior Technical Consultant, Results for Development Institute
Ms. Angeline Nanni
Director of Global Access, Aeras